Screening for abuse risk in pain patients

Advances in Psychosomatic Medicine

Volumn 30, Issue , 2011, Pages 113-124

  Bohn, Tara M ^a   Levy, Lauren B ^a   Celin, Sheyla ^a   Starr, Tatiana D ^a   Passik, Steven D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ARTICLE; HUMAN; MASS SCREENING; METHODOLOGY; OPIATE ADDICTION; PAIN; PSYCHOLOGIC TEST; RISK ASSESSMENT; UNITED STATES;

ANALGESICS, OPIOID; HUMANS; MASS SCREENING; OPIOID-RELATED DISORDERS; PAIN; PSYCHOLOGICAL TESTS; RISK ASSESSMENT; UNITED STATES;

EID: 79955755721     PISSN: 00653268     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000324069     Document Type: Article

References (26)

1. Argoff CE: The coexistence of neuropathic pain, sleep, and psychiatric disorders: a novel treatment approach. Clin J Pain 2007;23:15-22.
2. Cicero TJ, Inciardi JA, Muñoz A: Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004. J Pain 2005;6:662-672. (Pubitemid 41395058)
3. Lipman AG: Does the DEA truly seek balance in pain medicine? A chronology of confusion that impedes good patient care. J Pain Palliat Care Pharmacother 2005;19:7-9. (Pubitemid 40594044)
4. Volkow ND: Scientific research on prescription drug abuse, before the Subcommittee on Crime and Drugs, Committee on the Judiciary and the Caucus on International Narcotics Control United States Senate. 2008. http://www. drugabuse.gov/Testimony /3-12-08Testimony.html (accessed May 10, 2008).
5. NSDUH Report: Patterns and trends in nonmedical prescription pain reliever use: 2002 to 2005. Rockville, Substance Abuse and Mental Health Services Administration, 2007.
6. Results from the 2005 National Survey on Drug Use and Health: national findings. 2006. http://www. oas.samhsa.gov/NSDUH/2k5NSDUH/2k5results. htm (accessed May 10, 2008).
7. Cleeland CS, Ryan KM: Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994;23:129-138.
8. Kroenke K, Spitzer RL, Williams JB: The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-613. (Pubitemid 32823891)
9. Stratford P W, Binkley J, Solomon P, Finch E, Gill C, Moreland J: Defining the minimum level of detectable change for the Roland-Morris questionnaire. Phys Ther 1996;76:359-365, discussion 366-368. (Pubitemid 126501431)
10. Atluri SL, Sudarshan G: Development of a screening tool to detect the risk of inappropriate prescription opioid use in patients with chronic pain. Pain Physician 2004;7:333-338. (Pubitemid 39206371)
11. Kirsh K, Jass C, Bennett DS, Hagen JE, Passik SD: Initial development of a survey tool to detect issues of chemical coping in chronic pain patients. Palliat Support Care 2007;5:219-226.
12. Belgrade MJ, Schamber CD, Lindgren BR: The DIRE score: predicting outcomes of opioid prescribing for chronic pain. J Pain 2006;7:671-681. (Pubitemid 44291603)
13. Webster LR, Webster RM: Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med 2005;6:432-442. (Pubitemid 43110296)
14. Butler SF, Budman SH, Fernandez K, Jamison RN: Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 2004;112: 65-75. (Pubitemid 39371021)
15. Akbik H, Butler SF, Budman SH, Fernandez K, Katz N P, Jamison RN: Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage 2006; 32:287-293. (Pubitemid 44376443)
16. Coambs R, Jarry JL, Santhiapillai AC, Abrahamsohn RV, et al: The SISAP: a new screening instrument for identifying potential opioid abusers in the management of chronic nonmalignant pain within general medical practice. Pain Res Manag 1996;1: 155-162.
17. Passik SD, Kirsh KL, Casper D: Addiction-related assessment tools and pain management: instruments for screening, treatment planning, and monitoring compliance. Pain Med 2008;9:S145-S166.
18. Nemes S, Rao PA, Zeiler C, Munly K, Holtz KD, Hoffman J: Computerized screening of substance abuse problems in a primary care setting: older vs younger adults. Am J Drug Alcohol Abuse 2004; 30:627-642. (Pubitemid 39430693)
19. Yudko E, Lozhkina O, Fouts A: A comprehensive review of the psychometric properties of the Drug Abuse Screening Test. J Subst Abuse Treat 2007; 32:189-198. (Pubitemid 46240723)
20. Kellogg SH, McHugh PF, Bell K, Schluger JH, Schluger R P, LaForge KS, Ho A, Kreek MJ: The Kreek-McHugh-Schluger-Kellogg scale: a new, rapid method for quantifying substance abuse and its possible applications. Drug Alcohol Depend 2003;69:137-150. (Pubitemid 36259776)
21. Lazowski LE, Miller FG, Boye M W, Miller GA: Efficacy of the Substance Abuse Subtle Screening Inventory-3 (SASSI-3) in identifying substance dependence disorders in clinical settings. J Pers Assess 1998;71:114-128. (Pubitemid 28493694)
22. Brown RL, Leonard T, Saunders LA, Papasouliotis O: A two-item conjoint screen for alcohol and other drug problems. J Am Board Fam Pract 2001; 14:95-106. (Pubitemid 33705684)
23. Cacciola JS, Alterman AI, O'Brien CP, McLellan AT: The Addiction Severity Index in clinical efficacy trials of medications for cocaine dependence. NIDA Res Monogr 1997;175:182-191.
24. McLellan AT, Luborsky L, Woody GE, O'Brien CP: An improved diagnostic evaluation instrument for substance abuse patients: the Addiction Severity Index. J Nerv Ment Dis 1980;168:26-33. (Pubitemid 10187569)
25. Jonasson U, Jonasson B, Wickström L, Andersson E, Saldeen T: Analgesic use disorders among orthopedic and chronic pain patients at a rehabilitation clinic. Subst Use Misuse 1998;33:1375-1385. (Pubitemid 28208457)
26. Passik SD, Weinreb HJ: Managing chronic nonma-lignant pain: overcoming obstacles to the use of opioids. Adv Ther 2000;17:70-83. (Pubitemid 30419036)